A new trading day began on Monday, with Capricor Therapeutics Inc (NASDAQ: CAPR) stock price up 6.08% from the previous day of trading, before settling in for the closing price of $27.81. CAPR’s price has ranged from $4.30 to $40.37 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 11.01% over the last five years. Meanwhile, its annual earnings per share averaged -85.39%. With a float of $47.82 million, this company’s outstanding shares have now reached $54.40 million.
The firm has a total of 160 workers. Let’s measure their productivity.
Capricor Therapeutics Inc (CAPR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Capricor Therapeutics Inc is 12.10%, while institutional ownership is 31.82%.
Capricor Therapeutics Inc (CAPR) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.16 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -85.39% per share during the next fiscal year.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Here are Capricor Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 144.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach 0.32 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Analysing the last 5-days average volume posted by the [Capricor Therapeutics Inc, CAPR], we can find that recorded value of 1.34 million was lower than the volume posted last year of 2.15 million. As of the previous 9 days, the stock’s Stochastic %D was 52.19%.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 69.86%, which indicates a significant increase from 42.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.60 in the past 14 days, which was higher than the 0.92 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.98, while its 200-day Moving Average is $9.93. Now, the first resistance to watch is $30.41. This is followed by the second major resistance level at $31.31. The third major resistance level sits at $32.63. If the price goes on to break the first support level at $28.19, it is likely to go to the next support level at $26.87. Now, if the price goes above the second support level, the third support stands at $25.97.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
With a market capitalization of 1.60 billion, the company has a total of 45,718K Shares Outstanding. Currently, annual sales are 22,270 K while annual income is -40,470 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,570 K.
